Glass House Brands (GLAS) Operating Margin (2020 - 2026)
Glass House Brands' (GLAS) quarterly Operating Margin came in at 35.42% in Q1 2026, down 8.5% on a QoQ basis from 32.64% in Q4 2025.
Glass House Brands (GLAS) Operating Margin (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Operating Margin data on file, last reported at 35.42% in Q1 2026.
- On a quarterly basis, Operating Margin changed N/A year-over-year to 35.42% in Q1 2026; TTM through Mar 2026 was 15.63%, a N/A change from a year earlier, with the FY2025 full-year figure at 9.08%, down 1194.0% from the prior year.
- Operating Margin for Q1 2026 stood at 35.42%, down from 32.64% in the prior quarter.
- Over the last five years, Operating Margin for GLAS reached as high as 17.77% in Q2 2025 and fell as low as 98.5% in Q1 2022.
- Historically, Operating Margin has averaged 23.7% across 5 years, with a median of 31.12% in 2025.
- On a YoY basis, Operating Margin climbed as much as 2000000000 bps in 2022 and fell as far as 14003 bps in 2022.
- Year by year, Operating Margin stood at 32.88% in 2022, then surged by 100 bps to 0.0% in 2023, then jumped by 129563047 bps to 9.35% in 2024, then slumped by 449 bps to 32.64% in 2025, then declined by 8 bps to 35.42% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 35.42% in Q1 2026, 32.64% in Q4 2025, and 29.6% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.69% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 21.23% |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | -35.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.42% |
| Dec 31, 2025 | -32.64% |
| Sep 30, 2025 | -29.60% |
| Jun 30, 2025 | 17.77% |
| Jun 30, 2024 | 9.35% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | -32.88% |
| Sep 30, 2022 | -35.03% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -98.50% |
| Dec 31, 2021 | 107.15% |
| Sep 30, 2021 | -55,427,440.02% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -32.54% |
| Dec 31, 2020 | -2.18% |
| Sep 30, 2020 | -8.61% |
| Mar 31, 2020 | -64.74% |